PharmaVoice
AUGUST 4, 2022
Companies like Cost Plus Drugs and DiRx can bring generics directly to consumers at a fraction of the price, but whether it’s enough to fix the inflated U.S. healthcare system is yet to be seen.
Pharmacy Times
AUGUST 4, 2022
American Diabetes Association updates recommendations regarding SGLT-2 inhibitors, GLP-1 RA, and finerenone for cardiovascular and renal comorbidities.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PhRMA
AUGUST 4, 2022
I recently joined PhRMA board members in penning the letter below to Congress, urging them to abandon their latest drug pricing proposal.
Pharmaceutical Technology
AUGUST 4, 2022
Soaring patient numbers are stretching hospital capacity across the globe, forcing healthcare providers and their partners to think laterally about how to meet the demand without doubling their resources. Smarter diagnostic tools and more sophisticated remote- and self-care models will have an increasingly important role to play, as long as any advances are seen to deliver excellent outcomes and a better patient experience.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
AUGUST 4, 2022
Pharmacists need to focus on taking care of themselves while they continue to take care of others in even bigger ways post-COVID-19 pandemic.
Pharmaceutical Technology
AUGUST 4, 2022
North America extended its dominance for machine learning hiring among pharmaceutical industry companies in the three months ending May. The number of roles in North America made up 63.9% of total machine learning jobs - up from 62.6% in the same quarter last year. That was followed by Europe, which saw a 0.6 year-on-year percentage point change in machine learning roles.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
AUGUST 4, 2022
Two phase 3 trials of Merck & Co’s Keytruda in metastatic castration-resistant prostate cancer (CRPC) and advanced liver cancer have ended in failure, proving once again that cancer immunotherapy studies can be a hit-and-miss affair. The CRPC trial – KEYNOTE-921 – looked at the combination of Keytruda (pembrolizumab) with docetaxel in more than 1,000 patients who had not been treated with chemotherapy before, but who had seen disease progression despite earlier treatment with an anti-h
Pharmacy Times
AUGUST 4, 2022
The effective preventive treatment could reduce HIV rates but needs greater access and affordability, especially among Black and Latino populations, investigators contend.
PharmExec
AUGUST 4, 2022
Pharma companies may benefit from meeting challenges and embracing small molecule drug discovery.
The FDA Law Blog
AUGUST 4, 2022
By Sophia R. Gaulkin & Alan M. Kirschenbaum — In a recent decision, the Second Circuit upheld the HHS Office of the Inspector General (OIG)’s position that Pfizer’s proposed copay assistance program for its high-cost heart treatment would violate the Federal Anti-Kickback Statute (AKS). Pfizer, Inc. v. U.S. Department of Health and Human Services et al. , July 25, 2022.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
AUGUST 4, 2022
Ten months after ChemoCentryx scored an unexpected FDA approval for autoimmune disease therapy Tavneos, Amgen has swooped in with a $3.7 billion bid to buy out the company. The $52-per-share offer would give Amgen a drug that some analysts have described as a pipeline in a pill with $1 billion-plus sales potential, and is a sizeable premium on ChemoCentryx’ pre-deal announcement share price of just over $24.
Pharmacy Times
AUGUST 4, 2022
Exploring the significant role of electronic medical records (EMR) in toxicity management for patients with HR+/HER2– breast cancer.
PharmExec
AUGUST 4, 2022
Better clinical data needed, as well as strategies for tackling opioid abuse, tobacco use, and food safety.
Outsourcing Pharma
AUGUST 4, 2022
An expert from the trial tech firm explains how the 21st Century Cures Act and other recent regulatory advancements can elevate clinical data registries.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Honest Apothecary
AUGUST 4, 2022
If you were to ask me what I honestly believe the most desperately needed role in healthcare today is, I think most people would be surprised. I love doctors, nurses, physician’s assistants and pharmacists…but none of those are it. I love physical therapists, and radiologists and technicians, but while important, those aren’t the greatest need.
Pharmaceutical Commerce
AUGUST 4, 2022
Multi-year deal aims to put patients at the center of their clinical data.
Pharmacy Times
AUGUST 4, 2022
If approved the drug will be the first allogeneic advanced stem cell therapy donor source for patients with blood cancers.
pharmaphorum
AUGUST 4, 2022
Pfizer has stopped development of a drug to treat cardiomyopathy caused by a rare form of heart disease, after it proved ineffective in a phase 3 trial. PF-07265803 – a p38 mitogen-activated protein kinase (MAPK) antagonist also known as emprumapimod – was being tested as a treatment for symptomatic dilated cardiomyopathy (DCM) due to a mutation in the LMNA gene in the REALM-DCM trial.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
AUGUST 4, 2022
SilverSeal provides topical management of minor superficial wounds, lacerations, and abrasions, as well as minor first-degree burns.
Pharmaceutical Technology
AUGUST 4, 2022
Sinovac Biotech has reported that its Covid-19 vaccine, CoronaVac, obtained approval from the Health Bureau of the Government of the Hong Kong Special Administrative Region of the People's Republic of China for usage in children of the age six months to three years. The consensus interim recommendations on Covid-19 vaccine use in children aged six months or above in Hong Kong were released by the Scientific Committee on Vaccine Preventable Diseases and the Scientific Committee on Emerging and Zo
Pharmacy Times
AUGUST 4, 2022
Brinzolamide/brimonidine tartrate (Simbrinza) is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Outsourcing Pharma
AUGUST 4, 2022
This monthâs announcements of appointments, partnerships, expansions, and mergers include Curia, Thread, TFF Pharmaceuticals, and other notable companies.
Pharmaceutical Technology
AUGUST 4, 2022
Poseida Therapeutics and Roche have signed a strategic partnership and licence agreement to develop allogeneic CAR-T cell therapies for hematologic malignancies. The research and development (R&D) of various present and new ‘off-the-shelf’ cell therapies against targets in B-cell lymphomas, multiple myeloma and other hematologic indications are included in this alliance.
InCrowd
AUGUST 4, 2022
It is impossible to describe the human experience as a single interaction, a single moment, or a single life. Many of us are the result of the intersection between our race, ethnicity, gender, age, religious beliefs, sexual orientation, and gender identity. Intersectionality is an analytical framework for understanding how aspects of a person’s social and political identities combine to create different modes of discrimination and privilege.
PharmExec
AUGUST 4, 2022
Pharma companies must revise their recruitment strategies in the wake of a skills shortage.
Outsourcing Pharma
AUGUST 4, 2022
The pharmaceutical company has forged a partnership with the life-sciences tech firm in an effort to elevate data collection and speed up clinical studies.
PharmExec
AUGUST 4, 2022
How effective training programs enable ‘next-generation’ patient engagement.
Pharmaceutical Technology
AUGUST 4, 2022
Business optimism declined in July 2022 compared to June 2022, amid concerns over inflation as the cost-of-living pressures on households continued to grow in countries such as the UK, revealed the analysis of an ongoing poll by Verdict. Verdict has been conducting the poll to study the trends in business optimism during COVID-19 as reflected by the views of companies on their future growth prospects amid the pandemic.
pharmaphorum
AUGUST 4, 2022
Unlocking the secrets of the human genome has long been an ambitious pursuit for researchers around the world. Over the past two decades, innovative research efforts, such as the Human Genome Project and 100,000 Genomes Project, have vastly expanded our understanding of the human genome and its role in driving research and development in oncology. Understandably, these ground-breaking studies have captured the attention of many across the industry, acting as a catalyst for new research into the
PharmExec
AUGUST 4, 2022
In episode 114, Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, discusses why it’s important to manage high levels of workplace stress, and how companies can help employees in need.
Pharma Times
AUGUST 4, 2022
Candidate exhibits a novel mechanism of action and differs considerably from previously approved drugs
The FDA Law Blog
AUGUST 4, 2022
The American Conference Institute is hosting their 39th FDA Boot Camp from September 14-15, 2022. The conference will be held virtually. Gain insight and training in core regulatory concepts for life sciences attorneys, business executives, and policy analysts. The approval process, pre-approval concerns, product labeling, clinical trials, adverse events reports, patent concerns, and exclusivity – these are all critical aspects in the commercialization process for drugs and biologics that are g
Pharma Times
AUGUST 4, 2022
Senior NHS figures fear that the leadership contest is not addressing wider health service needs
Expert insights. Personalized for you.
246 
Let's personalize your content